Theraclion in brief

Based in Paris, Theraclion is an echotherapy specialist and leader in non-invasive treatment of benign tumours with high-intensity focused ultrasound (HIFU) guided by real-time ultrasound imaging.


The company has developed a medical device (Echopulse®) that combines advanced ultrasound imaging and HIFU therapy.

Theraclion is ISO 13485 certified and has received the CE mark for non-invasive ablation of breast fibroadenomas and thyroid nodules.

A full 53% of its 24-strong team are dedicated to R&D and clinical trials.